EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Predictors of a Gabapentinoid–Loop‐Diuretic Prescribing Cascade in U.S. Nursing Home Residents

Kaleen N Hayes iD, Emmanuelle Belanger, Arman Oganisian, Richa Joshi, Xiao Joyce Wang, Lexie R Grove, Kelsey L Corcoran, Andrew R Zullo iD

Journal of the American Geriatrics Society · 2026-02 · 74 (2) · 336-344

DOI: 10.1111/jgs.70219 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Geriatrics Society, online erschienen am 28.11.2025. Verfasst von Kaleen N Hayes und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Services, Policy and Practice, Brown University School of Public Health, Providence, Rhode Island, USA. Hauptthemen laut MEDLINE: Gabapentin, Nursing Homes, Sodium Potassium Chloride Symporter Inhibitors, Edema. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gabapentinoid‐related peripheral edema may prompt loop diuretic prescribing. Nursing home (NH) residents may be especially prone to this prescribing cascade. We estimated the incidence and identified predictors of the gabapentinoid‐loop diuretic prescribing cascade in NHs.

Methods

We conducted a retrospective cohort study using 2016–2022 Medicare claims linked with Minimum Data Set assessments. We identified residents aged ≥ 66 years who initiated gabapentinoids in NHs and who had no evidence of loop diuretic use, heart failure, or renal insufficiency during the prior 6 months. The outcome was loop diuretic initiation within 90 days of gabapentinoid initiation. Using multivariable Poisson regression models, we estimated adjusted risk ratios (aRR) with 95% robust confidence intervals to identify predictors. We used pooled logistic regression models to examine the relationship between time‐varying gabapentinoid dose and loop diuretic initiation risk.

Results

Among 23,544 residents, 994 (4.2%) experienced a prescribing cascade at a median of 36 days (IQR 15–61) after gabapentinoid initiation. Risk was higher with age 86–90 years (aRR = 1.60) or ≥ 91 years (aRR = 1.38); a diagnosis of chronic pain or fibromyalgia (aRR = 1.16), or diabetes (aRR = 1.23); and receipt of potassium‐sparing diuretics (aRR = 1.53), thiazide diuretics (aRR = 1.27), or 15 or more unique medications (aRR = 1.18). Higher (versus lower) weekly gabapentin dose during follow‐up was associated with a 1.45 times higher prescribing cascade risk over 13 weeks. Those with Alzheimer's Disease and Related Dementias (aRR = 0.79), or moderate (aRR = 0.72) to severe cognitive impairment (aRR = 0.59) had a lower risk versus those with intact cognition.

Conclusions

Approximately 1 in 20 NH residents who initiate gabapentinoids receives a loop diuretic within 3 months. Potentially modifiable predictors included existing polypharmacy and titrating gabapentinoid doses. NH clinicians should monitor for edema soon after gabapentinoid initiation and consider dose reductions or discontinuation before adding a loop diuretic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GabapentinNursing HomesSodium Potassium Chloride Symporter InhibitorsEdemaPractice Patterns, Physicians'HumansMaleFemaleAgedAged, 80 and overRetrospective StudiesUnited StatesMedicare

Stichwörter der Autor:innen

adverse drug effectsdiureticsgabapentinnursing homespharmacoepidemiologypolypharmacy

Substanzen

GabapentinSodium Potassium Chloride Symporter Inhibitors

Autor:innen und Institutionen

  • Department of Health Services, Policy and Practice, Brown University School of Public Health, Providence, Rhode Island, USA.
  • Center for Gerontology and Healthcare Research, Brown University School of Public Health, Providence, Rhode Island, USA.
  • Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island, USA.
  • Department of Biostatistics, Brown University School of Public Health, Providence, Rhode Island, USA.

ORCID-Profile: Kaleen N Hayes, Andrew R Zullo

Förderung

  • NIA NIH HHS
  • National Institute on Aging

Zitieren

APA

Hayes, K. N., Belanger, E., Oganisian, A., Joshi, R., Wang, X. J., Grove, L. R., Corcoran, K. L., & Zullo, A. R. (2026). Predictors of a Gabapentinoid–Loop‐Diuretic Prescribing Cascade in U.S. Nursing Home Residents. Journal of the American Geriatrics Society, 74(2), 336-344. https://doi.org/10.1111/jgs.70219

Vancouver

Hayes KN, Belanger E, Oganisian A, Joshi R, Wang XJ, Grove LR, et al. Predictors of a Gabapentinoid–Loop‐Diuretic Prescribing Cascade in U.S. Nursing Home Residents. Journal of the American Geriatrics Society. 2026;74(2):336-344. doi:10.1111/jgs.70219

BibTeX
@article{Hayes2026,
  author = {Hayes, Kaleen N and Belanger, Emmanuelle and Oganisian, Arman and Joshi, Richa and Wang, Xiao Joyce and Grove, Lexie R and Corcoran, Kelsey L and Zullo, Andrew R},
  title = {Predictors of a Gabapentinoid–Loop‐Diuretic Prescribing Cascade in U.S. Nursing Home Residents},
  journal = {Journal of the American Geriatrics Society},
  year = {2026},
  volume = {74},
  number = {2},
  pages = {336--344},
  doi = {10.1111/jgs.70219}
}
Kostenlos starten →